TY - JOUR
AU - Fraszczyk, Eliza
AU - Spijkerman, Annemieke M W
AU - Zhang, Yan
AU - Brandmaier, Stefan
AU - Day, Felix R
AU - Zhou, Li
AU - Wackers, Paul
AU - Dollé, Martijn E T
AU - Bloks, Vincent W
AU - Gào, Xīn
AU - Gieger, Christian
AU - Kooner, Jaspal
AU - Kriebel, Jennifer
AU - Picavet, H Susan J
AU - Rathmann, Wolfgang
AU - Schöttker, Ben
AU - Loh, Marie
AU - Verschuren, W M Monique
AU - van Vliet-Ostaptchouk, Jana V
AU - Wareham, Nicholas J
AU - Chambers, John C
AU - Ong, Ken K
AU - Grallert, Harald
AU - Brenner, Hermann
AU - Luijten, Mirjam
AU - Snieder, Harold
TI - Epigenome-wide association study of incident type 2 diabetes: a meta-analysis of five prospective European cohorts.
JO - Diabetologia
VL - 65
IS - 5
SN - 0012-186X
CY - Heidelberg
PB - Springer
M1 - DKFZ-2022-00374
SP - 763-776
PY - 2022
N1 - 2022 May;65(5):763-776
AB - Type 2 diabetes is a complex metabolic disease with increasing prevalence worldwide. Improving the prediction of incident type 2 diabetes using epigenetic markers could help tailor prevention efforts to those at the highest risk. The aim of this study was to identify predictive methylation markers for incident type 2 diabetes by combining epigenome-wide association study (EWAS) results from five prospective European cohorts.We conducted a meta-analysis of EWASs in blood collected 7-10 years prior to type 2 diabetes diagnosis. DNA methylation was measured with Illumina Infinium Methylation arrays. A total of 1250 cases and 1950 controls from five longitudinal cohorts were included: Doetinchem, ESTHER, KORA1, KORA2 and EPIC-Norfolk. Associations between DNA methylation and incident type 2 diabetes were examined using robust linear regression with adjustment for potential confounders. Inverse-variance fixed-effects meta-analysis of cohort-level individual CpG EWAS estimates was performed using METAL. The methylGSA R package was used for gene set enrichment analysis. Confirmation of genome-wide significant CpG sites was performed in a cohort of Indian Asians (LOLIPOP, UK).The meta-analysis identified 76 CpG sites that were differentially methylated in individuals with incident type 2 diabetes compared with control individuals (p values <1.1 × 10-7). Sixty-four out of 76 (84.2
KW - Biomarkers (Other)
KW - DNA methylation (Other)
KW - Epigenetics (Other)
KW - Epigenome-wide association studies (Other)
KW - Meta-analysis (Other)
KW - Prediction (Other)
KW - Prospective studies (Other)
KW - Type 2 diabetes (Other)
LB - PUB:(DE-HGF)16
C6 - pmid:35169870
DO - DOI:10.1007/s00125-022-05652-2
UR - https://inrepo02.dkfz.de/record/178958
ER -